Cord Blood America, Inc Announces Financial Results for the First Quarter Ended March 31, 2017
May 15, 2017 at 08:16 am EDT
Share
Cord Blood America, Inc. announced financial results for the first quarter ended March 31, 2017. For the period, Total revenue for the first quarter was $0.75 million, a decrease of 24.4% from total revenue of $0.99 million for the first quarter 2016. EBITDA for the first quarter 2017 was $0.16 million, an increase of 100.3% from EBITDA of $0.08 million for the first quarter 2016. Net income for the three months ended March 31, 2017 was $0.12 million compared to a loss of $0.008 million in first quarter 2016.
CBA Florida, Inc., formerly Cord Blood America, Inc., through its CorCell program and its subsidiary CorCell Companies, Inc., provides cord blood and cord tissue stem cell services. The Company's subsidiaries include Cord Partners, Inc., CorCell Companies, Inc., CorCell, Ltd., (Cord Partners, Inc., CorCell Companies, Inc. and CorCell, Ltd. are referred to collectively as Cord), CBA Properties, Inc. (Properties), and Career Channel, Inc. The Company and its subsidiaries provides private cord blood and cord tissue stem cell storage services to families throughout the United States and Puerto Rico, and Properties was formed to hold corporate trademarks and other intellectual property. Cord's operations provide umbilical cord blood banking and cord tissue services to expectant parents. Cord provides various services, which includes collection materials, physician and customer support, transportation, testing and cord blood storage.
CBA FLORIDA, INC. 
